Is olanzapine overrated for acute mania?

🧠 Olanzapine has built a reputation as a heavy-hitter for treating acute manic episodes—but the data tells a more modest story.

In one key study comparing olanzapine vs. placebo over 3 weeks:

• Response rate: 55% (olanzapine) vs. 30% (placebo)
• Remission rate: 18% (olanzapine) vs. 7% (placebo)

That’s a 25% absolute difference in response and just an 11% difference in remission—not exactly blockbuster results.

This doesn’t mean olanzapine has no role in mania treatment. But it’s time to recalibrate our expectations and remain clear-eyed about what the data shows.

💊 Efficacy matters. So does the narrative we build around our tools.